SGMO
Sangamo Therapeutics, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.36
$-0.03
(-7.64%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $121.21M | EPS (ttm) | $-0.45 | Current Price | $0.36 |
| Enterprise Value | $127.04M | Forward EPS | $-0.23 | Previous Close | $0.39 |
| P/E Ratio | - | ROA | -68.11% | 52W High | $1.40 |
| Forward P/E | -1.57 | ROE | -480.02% | 52W Low | $0.36 |
| PEG Ratio | - | Gross Margin | -219.11% | 50 Day Avg | $0.44 |
| P/S Ratio | 3.69 | Operating Margin | -6119.28% | 200 Day Avg | $0.53 |
| P/B Ratio | 18.96 | Profit Margin | - | Volume | 15.10M |
| EV/EBITDA | -1.21 | Current Ratio | 0.88 | Avg Volume | 7.04M |
| EV/Sales | 3.86 | Quick Ratio | 0.69 | Beta | 1.31 |
| Employees | 183.00 | Debt/Equity | 407.24 | Shares Outstanding | 336.49M |
| Sector | Healthcare | Total Debt | $25.42M | Float Shares | 329.13M |
| Industry | Biotechnology | Total Cash | $29.62M | Short Float | 6.27% |
| Optionable | Yes | Cash/Share | $0.09 | Short Ratio | 5.34 |
| Dividend Yield | - | Book Value/Share | $0.02 | % Held by Insiders | 2.21% |
| Target Price | $3.81 | Revenue (TTM) | $32.88M | % Held by Institutions | 18.71% |